TWO common drugs used in the treatment of diabetes have been withdrawn from the Bahrain market, due to concerns about their effectiveness.
Glynase 5mg Tablet and Diatab 5mg Tablet are generic medication, but were deemed to fall below the standards of the treatment on which they were based .